Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Katarzyna Dominika Sluzalska"'
Autor:
Jakub Szymczyk, Martyna Sochacka, Martyna Biadun, Katarzyna Dominika Sluzalska, Danuta Witkowska, Malgorzata Zakrzewska
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundChemoresistance of cancer cells, resulting from various mechanisms, is a significant obstacle to the effectiveness of modern cancer therapies. Targeting fibroblast growth factors (FGFs) and their receptors (FGFRs) is becoming crucial, as th
Externí odkaz:
https://doaj.org/article/f836091aa95444dc86e8509c56fc8dad
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 12, p 10143 (2023)
Targeting fibroblast growth factor receptor 1 (FGFR1) is a promising therapeutic strategy for various cancers associated with alterations in the FGFR1 gene. In this study, we developed a highly cytotoxic bioconjugate based on fibroblast growth factor
Externí odkaz:
https://doaj.org/article/a2fa2d93cc994de89c18a0672f4d782f
Autor:
Agata Lampart, Katarzyna Dominika Sluzalska, Aleksandra Czyrek, Aleksandra Szerszen, Jacek Otlewski, Antoni Wiedlocha, Malgorzata Zakrzewska
Publikováno v:
Cells, Vol 11, Iss 3, p 522 (2022)
Fibroblast growth factor 1 (FGF1) is considered primarily as a ligand for FGF surface receptors (FGFRs) through which it activates a number of cellular responses. In addition to its canonical mode of action, FGF1 can act intracellularly, before secre
Externí odkaz:
https://doaj.org/article/41d0f56d64a545c48e40ab212141675f
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 12; Pages: 10143
Targeting fibroblast growth factor receptor 1 (FGFR1) is a promising therapeutic strategy for various cancers associated with alterations in the FGFR1 gene. In this study, we developed a highly cytotoxic bioconjugate based on fibroblast growth factor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::2bc241c609c839513ef2c8e52782238f
Autor:
Agata Lampart, Jakub Sławski, Katarzyna Dominika Sluzalska, Malgorzata Zakrzewska, Jacek Otlewski, Martyna Sochacka
Publikováno v:
Cytokine & Growth Factor Reviews. 57:93-111
Fibroblast growth factors 1 and 2 (FGF1 and FGF2) are mainly considered as ligands of surface receptors through which they regulate a broad spectrum of biological processes. They are secreted in non-canonical way and, unlike other growth factors, the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12338fb0dc379fac3af3378922f9d939
https://doi.org/10.1016/j.cytogfr.2020.05.004
https://doi.org/10.1016/j.cytogfr.2020.05.004
Autor:
Agata Lampart, Katarzyna Dominika Sluzalska, Aleksandra Czyrek, Aleksandra Szerszen, Jacek Otlewski, Antoni Wiedlocha, Malgorzata Zakrzewska
Publikováno v:
Cells; Volume 11; Issue 3; Pages: 522
Cells, Vol 11, Iss 522, p 522 (2022)
Cells, Vol 11, Iss 522, p 522 (2022)
Fibroblast growth factor 1 (FGF1) is considered primarily as a ligand for FGF surface receptors (FGFRs) through which it activates a number of cellular responses. In addition to its canonical mode of action, FGF1 can act intracellularly, before secre
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57caba02f1bec0682d9a01db9e73ef70
https://pubmed.ncbi.nlm.nih.gov/35159330
https://pubmed.ncbi.nlm.nih.gov/35159330